{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T18:25:23Z","timestamp":1783448723756,"version":"3.55.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,19]],"date-time":"2024-08-19T00:00:00Z","timestamp":1724025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["RG92770"],"award-info":[{"award-number":["RG92770"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000735","name":"University of Cambridge","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["NIHR200929"],"award-info":[{"award-number":["NIHR200929"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.vaccine.2024.126240","type":"journal-article","created":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T15:19:56Z","timestamp":1724339996000},"page":"126240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Estimating the potential number of cases prevented by infant\/ toddler immunisation with a MenACWY vaccine"],"prefix":"10.1016","volume":"42","author":[{"given":"L.","family":"Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Karachaliou","family":"Prasinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hadley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Trotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.126240_bb0005","author":"Oxford Vaccine Group. Meningococcal Disease"},{"key":"10.1016\/j.vaccine.2024.126240_bb0010","doi-asserted-by":"crossref","first-page":"B64","DOI":"10.1016\/j.vaccine.2009.04.061","article-title":"Meningococcal carriage and disease\u2014population biology and evolution","volume":"27","author":"Caugant","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126240_bb0015","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/j.cmi.2022.07.004","article-title":"Impact of meningococcal ACWY conjugate vaccines on pharyngeal carriage in adolescents: evidence for herd protection from the UK MenACWY programme","volume":"28","author":"Carr","year":"2022","journal-title":"Clin Microbiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2024.126240_bb0020","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1086\/527401","article-title":"Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity","volume":"197","author":"Maiden","year":"2008","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2024.126240_bb0025","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1056\/NEJMoa1900236","article-title":"Meningococcal B vaccine and meningococcal carriage in adolescents in Australia","volume":"382","author":"Marshall","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2024.126240_bb0030","author":"JCVI"},{"key":"10.1016\/j.vaccine.2024.126240_bb0035","author":"JCVI"},{"key":"10.1016\/j.vaccine.2024.126240_bb0040","author":"JCVI"},{"key":"10.1016\/j.vaccine.2024.126240_bb0045","first-page":"349","article-title":"Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study","author":"Christensen","year":"2014","journal-title":"Bmj"},{"key":"10.1016\/j.vaccine.2024.126240_bb0050","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1017\/S0950268823000870","article-title":"Modelling the impact of COVID-19 and routine MenACWY vaccination on meningococcal carriage and disease in the UK","volume":"151","author":"Hadley","year":"2023","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2024.126240_bb0055","series-title":"Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: Comparison of UKMenCar1\u20134 cross-sectional survey results","author":"MacLennan","year":"2020"},{"issue":"10","key":"10.1016\/j.vaccine.2024.126240_bb0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-037358","article-title":"Be on the TEAM\u2019Study (teenagers against meningitis): protocol for a controlled clinical trial evaluating the impact of 4CMenB or MenB-fHbp vaccination on the pharyngeal carriage of meningococci in adolescents","volume":"10","author":"Carr","year":"2020","journal-title":"BMJ Open"},{"issue":"12","key":"10.1016\/j.vaccine.2024.126240_bb0065","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","article-title":"Meningococcal carriage by age: a systematic review and meta-analysis","volume":"10","author":"Christensen","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126240_bb0070","series-title":"Meningococcal ACWY (MenACWY) vaccine coverage for adolescents in England, academic year 2019 to 2020","author":"PHE","year":"2024"},{"issue":"2","key":"10.1016\/j.vaccine.2024.126240_bb0075","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2193","article-title":"Effectiveness and duration of protection of one dose of a meningococcal conjugate vaccine","volume":"139","author":"Cohn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2024.126240_bb0080","series-title":"Childhood vaccination coverage statistics - England 2021","author":"NHS digital","year":"2022"},{"issue":"7","key":"10.1016\/j.vaccine.2024.126240_bb0085","doi-asserted-by":"crossref","first-page":"e1661","DOI":"10.1093\/cid\/ciaa1244","article-title":"First real-world evidence of meningococcal group B vaccine, 4CMenB, protection against meningococcal group W disease: prospective enhanced national surveillance","volume":"73","author":"Ladhani","year":"2021","journal-title":"England Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2024.126240_bb0090","series-title":"Meningococcal Laboratory confirmed cases [Unpublished data]","author":"UKHSA","year":"2022"},{"key":"10.1016\/j.vaccine.2024.126240_bb0095","author":"UKHSA"},{"key":"10.1016\/j.vaccine.2024.126240_bb0100","author":"UKHSA"},{"key":"10.1016\/j.vaccine.2024.126240_bb0105","author":"JCVI"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24009228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T05:48:20Z","timestamp":1778737700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24009228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":21,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S0264410X24009228"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126240","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the potential number of cases prevented by infant\/ toddler immunisation with a MenACWY vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.126240","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"126240"}}